Volume 2 - Issue 6 - June 2002
Feature
Feature Story
05/03/2008
Every medical device has to pass a series of tests before it can be made available for general use on human patients. This is a long, arduous process with many unknowns and potential roadblocks along the way.
Every medical device has to pass a series of tests before it can be made available for general use on human patients. This is a long, arduous process with many unknowns and potential roadblocks along the way.
Every medical device has to pass...
05/03/2008
EP Lab Digest
Feature Story
05/03/2008
Patients with atrial flutter have been exposed to anticoagulation therapy, cardioversion and drug regimens to control rate and protect them from the symptoms. When these therapies grow old or are no longer effective, they look to their...
Patients with atrial flutter have been exposed to anticoagulation therapy, cardioversion and drug regimens to control rate and protect them from the symptoms. When these therapies grow old or are no longer effective, they look to their...
Patients with atrial flutter...
05/03/2008
EP Lab Digest
Feature Story
05/03/2008
In 1991, the Sudden Arrhythmias Death Syndromes (SADS) Foundation was established as a nonprofit organization. Its mission was conceived as, and remains, to save the lives of children and others who are predisposed, or otherwise susceptible...
In 1991, the Sudden Arrhythmias Death Syndromes (SADS) Foundation was established as a nonprofit organization. Its mission was conceived as, and remains, to save the lives of children and others who are predisposed, or otherwise susceptible...
In 1991, the Sudden Arrhythmias...
05/03/2008
EP Lab Digest
Feature Story
05/03/2008
The treatment of certain arrhythmia substrates sometimes requires deeper and/or wider lesions than can be created with standard radiofrequency (RF) ablation. Typical atrial flutter is one of these substrates.
The treatment of certain arrhythmia substrates sometimes requires deeper and/or wider lesions than can be created with standard radiofrequency (RF) ablation. Typical atrial flutter is one of these substrates.
The treatment of certain...
05/03/2008
EP Lab Digest
Column
Feature Interview
05/03/2008
Cardionet Chairman and CEO James M. Sweeney has long been a leader in the health care industry. He is best known as the pioneer of the home infusion industry through Caremark, which he founded.
Cardionet Chairman and CEO James M. Sweeney has long been a leader in the health care industry. He is best known as the pioneer of the home infusion industry through Caremark, which he founded.
Cardionet Chairman and CEO James...
05/03/2008
EP Lab Digest
Feature Interview
05/03/2008
Read about his recent work in pulmonary vein isolation at the Cleveland Clinic.
Read about his recent work in pulmonary vein isolation at the Cleveland Clinic.
Read about his recent work in...
05/03/2008
EP Lab Digest
Spotlight Interview
05/03/2008
The Georgia Heart Center recently received a five-star report card rating from HealthGrades.com, Inc., reflecting the hospital's superior quality of care in its heart program. This rating places them in the top 10 percent of medical...
The Georgia Heart Center recently received a five-star report card rating from HealthGrades.com, Inc., reflecting the hospital's superior quality of care in its heart program. This rating places them in the top 10 percent of medical...
The Georgia Heart Center...
05/03/2008
EP Lab Digest
